Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Healthcare ITHospital IT

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1242190

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1242190

Clinical Decision Support Systems

PUBLISHED:
PAGES: 193 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5450
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 16350

Add to Cart

Description

Table of Contents

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Clinical Decision Support Systems Market to Reach $3 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Clinical Decision Support Systems estimated at US$1.6 Billion in the year 2022, is projected to reach a revised size of US$3 Billion by 2030, growing at aCAGR of 7.8% over the period 2022-2030. Services, one of the segments analyzed in the report, is projected to record 7.6% CAGR and reach US$1.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Hardware segment is readjusted to a revised 6.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $494.6 Million, While China is Forecast to Grow at 7.3% CAGR

The Clinical Decision Support Systems market in the U.S. is estimated at US$494.6 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$513.5 Million by the year 2030 trailing a CAGR of 7.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.2% and 6.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.3% CAGR.

Select Competitors (Total 43 Featured) -

  • Allscripts Healthcare Solutions, Inc.
  • Cerner Corporation
  • Elsevier BV
  • Epic Systems Corporation
  • Hearst Health
  • IBM Corporation
  • McKesson Corporation
  • MEDITECH
  • Philips Healthcare
  • Wolters Kluwer Health
Show more
Product Code: MCP11048

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Clinical Decision Support Systems - Global Key Competitors Percentage Market Share in 2021 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2021 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Clinical Decision Support Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Clinical Decision Support Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Standalone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Standalone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Standalone by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Integrated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Integrated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Integrated by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Therapeutic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Therapeutic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Therapeutic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Conventional by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Conventional by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 27: World 16-Year Perspective for Conventional by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Advanced by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Advanced by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 30: World 16-Year Perspective for Advanced by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 31: World Clinical Decision Support Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Clinical Decision Support Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Component - Services, Hardware and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Clinical Decision Support Systems by Component - Services, Hardware and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Services, Hardware and Software for the Years 2014, 2023 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Product - Integrated and Standalone - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Clinical Decision Support Systems by Product - Integrated and Standalone Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Integrated and Standalone for the Years 2014, 2023 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional and Advanced - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Clinical Decision Support Systems by Application - Conventional and Advanced Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional and Advanced for the Years 2014, 2023 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic and Diagnostic for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Component - Services, Hardware and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Clinical Decision Support Systems by Component - Services, Hardware and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Services, Hardware and Software for the Years 2014, 2023 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Product - Integrated and Standalone - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Clinical Decision Support Systems by Product - Integrated and Standalone Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Integrated and Standalone for the Years 2014, 2023 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional and Advanced - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Clinical Decision Support Systems by Application - Conventional and Advanced Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional and Advanced for the Years 2014, 2023 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic and Diagnostic for the Years 2014, 2023 & 2030
  • JAPAN
    • Clinical Decision Support Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Component - Services, Hardware and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Clinical Decision Support Systems by Component - Services, Hardware and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Services, Hardware and Software for the Years 2014, 2023 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Product - Integrated and Standalone - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Clinical Decision Support Systems by Product - Integrated and Standalone Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Integrated and Standalone for the Years 2014, 2023 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional and Advanced - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Clinical Decision Support Systems by Application - Conventional and Advanced Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional and Advanced for the Years 2014, 2023 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic and Diagnostic for the Years 2014, 2023 & 2030
  • CHINA
    • Clinical Decision Support Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Component - Services, Hardware and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Clinical Decision Support Systems by Component - Services, Hardware and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: China 16-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Services, Hardware and Software for the Years 2014, 2023 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Product - Integrated and Standalone - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Clinical Decision Support Systems by Product - Integrated and Standalone Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: China 16-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Integrated and Standalone for the Years 2014, 2023 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional and Advanced - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Clinical Decision Support Systems by Application - Conventional and Advanced Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: China 16-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional and Advanced for the Years 2014, 2023 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: China 16-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic and Diagnostic for the Years 2014, 2023 & 2030
  • EUROPE
    • Clinical Decision Support Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Clinical Decision Support Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Clinical Decision Support Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Component - Services, Hardware and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Clinical Decision Support Systems by Component - Services, Hardware and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Services, Hardware and Software for the Years 2014, 2023 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Product - Integrated and Standalone - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Clinical Decision Support Systems by Product - Integrated and Standalone Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Integrated and Standalone for the Years 2014, 2023 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional and Advanced - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Clinical Decision Support Systems by Application - Conventional and Advanced Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional and Advanced for the Years 2014, 2023 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic and Diagnostic for the Years 2014, 2023 & 2030
  • FRANCE
    • Clinical Decision Support Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Component - Services, Hardware and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Clinical Decision Support Systems by Component - Services, Hardware and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: France 16-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Services, Hardware and Software for the Years 2014, 2023 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Product - Integrated and Standalone - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Clinical Decision Support Systems by Product - Integrated and Standalone Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 100: France 16-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Integrated and Standalone for the Years 2014, 2023 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional and Advanced - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Clinical Decision Support Systems by Application - Conventional and Advanced Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 103: France 16-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional and Advanced for the Years 2014, 2023 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 106: France 16-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic and Diagnostic for the Years 2014, 2023 & 2030
  • GERMANY
    • Clinical Decision Support Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Component - Services, Hardware and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Clinical Decision Support Systems by Component - Services, Hardware and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Services, Hardware and Software for the Years 2014, 2023 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Product - Integrated and Standalone - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Clinical Decision Support Systems by Product - Integrated and Standalone Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 112: Germany 16-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Integrated and Standalone for the Years 2014, 2023 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional and Advanced - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Clinical Decision Support Systems by Application - Conventional and Advanced Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 115: Germany 16-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional and Advanced for the Years 2014, 2023 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 118: Germany 16-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic and Diagnostic for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Component - Services, Hardware and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Clinical Decision Support Systems by Component - Services, Hardware and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 121: Italy 16-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Services, Hardware and Software for the Years 2014, 2023 & 2030
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Product - Integrated and Standalone - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Clinical Decision Support Systems by Product - Integrated and Standalone Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 124: Italy 16-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Integrated and Standalone for the Years 2014, 2023 & 2030
    • TABLE 125: Italy Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional and Advanced - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for Clinical Decision Support Systems by Application - Conventional and Advanced Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 127: Italy 16-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional and Advanced for the Years 2014, 2023 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 130: Italy 16-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic and Diagnostic for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Clinical Decision Support Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 131: UK Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Component - Services, Hardware and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 132: UK Historic Review for Clinical Decision Support Systems by Component - Services, Hardware and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 133: UK 16-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Services, Hardware and Software for the Years 2014, 2023 & 2030
    • TABLE 134: UK Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Product - Integrated and Standalone - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 135: UK Historic Review for Clinical Decision Support Systems by Product - Integrated and Standalone Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 136: UK 16-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Integrated and Standalone for the Years 2014, 2023 & 2030
    • TABLE 137: UK Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional and Advanced - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Clinical Decision Support Systems by Application - Conventional and Advanced Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 139: UK 16-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional and Advanced for the Years 2014, 2023 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 142: UK 16-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic and Diagnostic for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Component - Services, Hardware and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Clinical Decision Support Systems by Component - Services, Hardware and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Services, Hardware and Software for the Years 2014, 2023 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Product - Integrated and Standalone - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Clinical Decision Support Systems by Product - Integrated and Standalone Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Integrated and Standalone for the Years 2014, 2023 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional and Advanced - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Clinical Decision Support Systems by Application - Conventional and Advanced Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 151: Rest of Europe 16-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional and Advanced for the Years 2014, 2023 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 154: Rest of Europe 16-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic and Diagnostic for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Clinical Decision Support Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Component - Services, Hardware and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Clinical Decision Support Systems by Component - Services, Hardware and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Services, Hardware and Software for the Years 2014, 2023 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Product - Integrated and Standalone - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Clinical Decision Support Systems by Product - Integrated and Standalone Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Integrated and Standalone for the Years 2014, 2023 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional and Advanced - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Clinical Decision Support Systems by Application - Conventional and Advanced Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 163: Asia-Pacific 16-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional and Advanced for the Years 2014, 2023 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 166: Asia-Pacific 16-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic and Diagnostic for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 167: Rest of World Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Component - Services, Hardware and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 168: Rest of World Historic Review for Clinical Decision Support Systems by Component - Services, Hardware and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 169: Rest of World 16-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Services, Hardware and Software for the Years 2014, 2023 & 2030
    • TABLE 170: Rest of World Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Product - Integrated and Standalone - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Rest of World Historic Review for Clinical Decision Support Systems by Product - Integrated and Standalone Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 172: Rest of World 16-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Integrated and Standalone for the Years 2014, 2023 & 2030
    • TABLE 173: Rest of World Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional and Advanced - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 174: Rest of World Historic Review for Clinical Decision Support Systems by Application - Conventional and Advanced Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 175: Rest of World 16-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional and Advanced for the Years 2014, 2023 & 2030
    • TABLE 176: Rest of World Recent Past, Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 177: Rest of World Historic Review for Clinical Decision Support Systems by Type - Therapeutic and Diagnostic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 178: Rest of World 16-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic and Diagnostic for the Years 2014, 2023 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!